2-(5-(4-butoxyphenyl)-2H-tetrazol-2-yl)-N-(2-methylnaphthalen-1-yl)acetamide

ID: ALA4582597

Chembl Id: CHEMBL4582597

PubChem CID: 3136444

Max Phase: Preclinical

Molecular Formula: C24H25N5O2

Molecular Weight: 415.50

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCOc1ccc(-c2nnn(CC(=O)Nc3c(C)ccc4ccccc34)n2)cc1

Standard InChI:  InChI=1S/C24H25N5O2/c1-3-4-15-31-20-13-11-19(12-14-20)24-26-28-29(27-24)16-22(30)25-23-17(2)9-10-18-7-5-6-8-21(18)23/h5-14H,3-4,15-16H2,1-2H3,(H,25,30)

Standard InChI Key:  IWGDWZCXISBDLZ-UHFFFAOYSA-N

Associated Targets(non-human)

Falcipain 2 (539 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cysteine protease falcipain-3 (103 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 415.50Molecular Weight (Monoisotopic): 415.2008AlogP: 4.62#Rotatable Bonds: 8
Polar Surface Area: 81.93Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.71CX Basic pKa: CX LogP: 5.77CX LogD: 5.77
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.42Np Likeness Score: -1.80

References

1. Gao C, Chang L, Xu Z, Yan XF, Ding C, Zhao F, Wu X, Feng LS..  (2019)  Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents.,  163  [PMID:30530192] [10.1016/j.ejmech.2018.12.001]

Source